Cardiology

Top Story

Rivaroxaban does not show noninferiority to vitamin K antagonists in antiphospholipid syndrome

October 14, 2019

Read the Perspective from Jori E. May, MD

Meeting News

Metabolic syndrome may play role in HFpEF risk

October 14, 2019
CHICAGO — Patients with metabolic syndrome are at risk for developing HF with preserved ejection fraction, although the mechanisms behind this risk are speculative…
Meeting News

Lp(a) has strong effect on CVD risk

October 14, 2019
CHICAGO — Lipoprotein(a) has been shown to be an independent, causal and genetic risk factor for CVD, with higher prevalence in patients of African, South Asian…
Meeting News

Quantitative flow ratio predicts outcomes in complex PCI

October 14, 2019
SAN FRANCISCO — Among patients with three-vessel disease who underwent PCI, achievement of a quantitative flow ratio of at least 0.91 in all treated vessels was…
Meeting News

Statin intolerance can be fought with intermittent dosing

October 14, 2019
CHICAGO —Intermittent statin dosing is a treatment option that may have tremendous potential for addressing patients with statin intolerance who are trying to…
More Headlines »